Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Medical College of Wisconsin
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)